Montelukast vs Sars-Cov-2 Virus Spike Protein
Montelukast vs Sars-Cov-2 Virus Spike Protein: Overview
This comparison examines the pharmacological differences between Montelukast and Sars-Cov-2 Virus Spike Protein.
Mechanism of Action
Montelukast: Selective leukotriene D4 receptor antagonist.
Pharmacokinetics
Half-life: Montelukast — 2.7-5.5 hours.
Chemical Properties
Molecular Formula: Montelukast — C35H36ClNO3S.
Molecular Weight: Montelukast — 586.1800 g/mol.
Type: Montelukast — Small molecule; Sars-Cov-2 Virus Spike Protein — Vaccine component.